The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Laboratorio Farmaceutico Erfo SpA 9-Day RSI Related Terms
MIL:ERFO vs KHC, GIS, HRL: 9-Day RSI Comparison
For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorio Farmaceutico Erfo SpA 9-Day RSI vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) has a 9-Day RSI of 66.51 as of Jul. 12, 2026. According to the industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #1842 out of 2105 companies in the Consumer Packaged Goods industry, placing it in the top 87.5%.
Is Laboratorio Farmaceutico Erfo SpA's 9-Day RSI too high?
Laboratorio Farmaceutico Erfo SpA's current 9-Day RSI is 66.51. The Consumer Packaged Goods industry median 9-Day RSI is 49.68. Laboratorio Farmaceutico Erfo SpA's value of 66.51 is 33.9% above this industry median. Based on the distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #1842 out of 2105 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Laboratorio Farmaceutico Erfo SpA has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorio Farmaceutico Erfo SpA's 9-Day RSI compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #1842 out of 2105 companies for 9-Day RSI. This places Laboratorio Farmaceutico Erfo SpA in the lower half of its industry. The industry median 9-Day RSI is 49.68. Laboratorio Farmaceutico Erfo SpA's value of 66.51 is 33.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Consumer Packaged Goods company?
The median 9-Day RSI among Consumer Packaged Goods companies is 49.68, based on 2,105 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laboratorio Farmaceutico Erfo SpA's current 9-Day RSI of 66.51 is 33.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median 9-Day RSI is 49.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorio Farmaceutico Erfo SpA's current 9-Day RSI is 66.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorio Farmaceutico Erfo SpA stock overvalued right now?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.12, compared to a current price of €1.20 — trading 43.6% below its estimated fair value. The current 9-Day RSI is 66.51 and 33.9% above the Consumer Packaged Goods industry median of 49.68. Laboratorio Farmaceutico Erfo SpA's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Laboratorio Farmaceutico Erfo SpA (MIL:ERFO), the current 9-Day RSI is 66.51 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA stock appears to be undervalued.
The current stock price of €1.20 is trading 43.6% below its estimated GF Value™ of €2.12.
GuruFocus considers Laboratorio Farmaceutico Erfo SpA to be Significantly Undervalued.
Key valuation signals for MIL:ERFO:
9-Day RSI: 66.51
GF Value™: €2.12 vs. price of €1.20 (43.6% below fair value)
Industry Position: 33.9% above the Consumer Packaged Goods median (#1842 of 2105)
No single metric tells the full story. See the MIL:ERFO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorio Farmaceutico Erfo SpA Business Description
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
66GF Score
Get the complete analysis for MIL:ERFO
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:ERFO has been successfully added to your 